Institutional Owners May Ignore ARS Pharmaceuticals, Inc.'s (NASDAQ:SPRY) Recent US$64m Market Cap Decline as Longer-term Profits Stay in the Green

Key Insights Given the large stake in the stock by institutions, ARS Pharmaceuticals' stock price might be vulnerable to their trading decisions 53% of the business is held by the top 7 shareholders

Simply Wall StJun 18 08:32 ET

ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$913.92K in Common Stock

$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder Tanimoto Sarina sold 100K shares of common stock on Jun 11, 12, 2024 at an average price of $9.1392 for a total value of $913.92K. This transaction invol

moomoo NewsJun 13 17:12 ET

Ars Pharmaceuticals Insider Sold Shares Worth $913,917, According to a Recent SEC Filing

Richard E Lowenthal, 10% Owner, Director, President and CEO, on June 11, 2024, sold 100,000 shares in Ars Pharmaceuticals (SPRY) for $913,917. Following the Form 4 filing with the SEC, Lowenthal has c

MT NewswiresJun 13 16:37 ET

Form 144 | ARS Pharmaceuticals(SPRY.US) Officer Proposes to Sell 2.7 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 11, $ARS Pharmaceuticals(SPRY.US)$ Officer Lowenthal Richard E intends to sell 300K shares of its common stock on Jun 11, with a total market value of approximately $2.7 mi

moomoo NewsJun 11 11:38 ET

ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$905.44K in Common Stock

$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder Lowenthal Richard E sold 100K shares of common stock on May 14, 15, 16, 2024 at an average price of $9.0544 for a total value of $905.44K. This transacti

moomoo NewsMay 16 20:35 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: ARS Pharmaceuticals (SPRY), AnaptysBio (ANAB) and Allakos (ALLK)

TipRanksMay 14 05:31 ET